RESIDUAL DETECTION KITS
Residual DetectION Kits
Allianz Bio, in partnership with ACRO Biosystems, provides the Residual Detection Kit (resDetect™)—a series of reagent kits developed to meet international regulatory guidelines for detecting residual components in biopharmaceutical manufacturing.
resDetect™ kits are applicable across a wide range of modalities, including antibody drugs, cell and gene therapies (CGT), and vaccines.
These kits offer comprehensive solutions for detecting common process-related residues such as host cell DNA, host cell protein, host cell RNA, protein A, tool enzymes, and cytokines, ensuring product safety and regulatory compliance throughout development and production.
More About Product
- We offer a comprehensive range of resDetect™ Residual Detection Kits designed to support biopharmaceutical development and regulatory compliance.
- Our catalog includes ELISA kits targeting a wide variety of residual components commonly found in biologics and cell and gene therapy products.
- We also offer kits for host cell proteins and ligands (CD5, DLL4, 4-1BBL), enzymes (Protein L, Pyrophosphatase, T7 RNA Polymerase, DNase, RNase), CRISPR-associated proteins (Cas9), and nucleases (GENIUS™ and Salt Active GENIUS™).
- Additionally, we provide resDNA detection solutions including sample preparation kits and qPCR-based quantitation kits. This diverse offering ensures you have the tools needed for effective and reliable residue monitoring across various therapeutic platforms.
